Newron Pharmaceuticals SpA (NWRN) — Free Cash Flow Generation Index

Latest as of June 2025: 1.00x

Newron Pharmaceuticals SpA (NWRN) has a Free Cash Flow Generation Index of 1.00x as of June 2025. Free cash flow of CHF33.32 Million represents 1% of operating cash flow (CHF33.35 Million). Read Newron Pharmaceuticals SpA debt and liabilities for a breakdown of total debt and financial obligations.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

CHF33.32 Million

CHF

Operating Cash Flow

CHF33.35 Million

CHF

Capital Expenditures

CHF31.00K

CHF

Newron Pharmaceuticals SpA Free Cash Flow Generation Index (2012–2025)

Historical FCF Generation Index trend for Newron Pharmaceuticals SpA across 2 annual periods. Explore Newron Pharmaceuticals SpA (NWRN) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Newron Pharmaceuticals SpA (2012–2025)

Year-by-year Free Cash Flow Generation Index for Newron Pharmaceuticals SpA. For the full company profile including market capitalisation, see NWRN stock market capitalisation.

Year	FCG Index	Free Cash Flow (CHF)	Operating CF	Capital Expenditures	YoY Change
2025	1.00x	CHF32.51 Million	CHF32.56 Million	CHF47.30K	▲ +0.0%
2012	1.00x	CHF5.81 Million	CHF5.83 Million	CHF11.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).